Showing results (211-220 of 244) with videos related to

Sort By:
Pageof 25
Journal of Neurophysiology|June 2, 2026
Connectivity of serotonin neurons reveals a constrained inhibitory subnetwork within the olfactory systemFarzaan Salman, Julius Jonaitis, Jacob D Ralston, et al.
International Journal of Environmental Research and Public Health|June 10, 2023
Leveraging the Expertise of the Community: A Case for Expansion of a Peer Workforce in Child, Adolescent, and Family Mental HealthHillary A Robertson, Matthew G Biel, Katherine R Hayes, et al.
Nature Communications|May 1, 2020
In-situ resonant band engineering of solution-processed semiconductors generates high performance n-type thermoelectric nano-inksAyaskanta Sahu, Boris Russ, Miao Liu, et al.
Clinical Nuclear Medicine|March 14, 2017
Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human PapillomavirusesEmily E Coates, Pamela J Costner, Martha C Nason, et al.
The Journal of Clinical Investigation|December 1, 2025
Distinct colitis-associated macrophages drive NOD2-dependent bacterial sensing and gut homeostasisGajanan D Katkar, Mahitha Shree Anandachar, Stella-Rita C Ibeawuchi, et al.
Clinical Pharmacology and Therapeutics|September 1, 2020
Model Informed Development of VRC01 in Newborn Infants Using a Population Pharmacokinetics ApproachJerry Li, Mina Nikanjam, Coleen K Cunningham, et al.
Molecular Microbiology|October 3, 2001
EmtA, a rRNA methyltransferase conferring high-level evernimicin resistanceP A Mann, L Xiong, A S Mankin, et al.
Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of adaptive and innate immune responses induced by licensed vaccines for Human PapillomavirusDouglas M Herrin, Emily E Coates, Pamela J Costner, et al.
NPJ Vaccines|December 22, 2017
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trialAdam D DeZure, Emily E Coates, Zonghui Hu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 10, 2023
Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitorsK D Lewis, K Peris, A Sekulic, et al.
Pageof 25